Therapeutic Asset Ratings
502 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Rilvegostomig
Head And Neck Squamous Cell Carcinoma
AstraZeneca
P1/2
CC
(41)
Rilvegostomig
Melanoma
AstraZeneca
P1/2
CC
(41)
Rilvegostomig
Renal Cell Carcinoma
AstraZeneca
P1/2
CC
(41)
T-Dxd
Cervical Cancer
AstraZeneca
P1/2
CC
(41)
T-Dxd
Endometrial Carcinoma
AstraZeneca
P1/2
CC
(41)
Torvutatug Samrotecan
Endometrial Carcinoma
AstraZeneca
P1/2
CC
(41)
Trastuzumab Deruxtecan
Renal Cell Carcinoma
AstraZeneca
P1/2
CC
(41)
azd0305
Plasma Cell Myeloma
AstraZeneca
P1/2
CC
(40)
azd5305
Colorectal Cancer
AstraZeneca
P1/2
CC
(40)
azd5305
Ovarian Cancer
AstraZeneca
P1/2
CC
(40)
azd5305
Pancreatic Neoplasm
AstraZeneca
P1/2
CC
(40)
azd6621
Prostate Cancer
AstraZeneca
P1/2
CC
(40)
azd6750
Non-Small Cell Lung Carcinoma
AstraZeneca
P1/2
CC
(40)
azd8853
Colorectal Cancer
AstraZeneca
P1/2
CC
(40)
azd9750
Prostate Cancer
AstraZeneca
P1/2
CC
(40)
Camizestrant
Colorectal Cancer
AstraZeneca
P1/2
CC
(40)
Camizestrant
Non-Small Cell Lung Carcinoma
AstraZeneca
P1/2
CC
(40)
Camizestrant
Ovarian Cancer
AstraZeneca
P1/2
CC
(40)
Camizestrant
Pancreatic Neoplasm
AstraZeneca
P1/2
CC
(40)
Camizestrant
Prostate Cancer
AstraZeneca
P1/2
CC
(40)
Datopotamab Deruxtecan
Pancreatic Neoplasm
AstraZeneca
P1/2
CC
(40)
Datopotamab Deruxtecan
Prostate Cancer
AstraZeneca
P1/2
CC
(40)
Palacaparib
Breast Cancer
AstraZeneca
P1/2
CC
(40)
Palacaparib
Ovarian Cancer
AstraZeneca
P1/2
CC
(40)
Puxitatug Samrotecan
Breast Cancer
AstraZeneca
P1/2
CC
(40)
Showing 376 to 400 of 502 assets
Previous
Page 16 of 21
Next
